News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

SafeStitch Medical, Inc. Announces Encouraging Result of Transluminal Procedure to Correct GERD and Obesity With Two Years Follow Up


1/22/2013 9:50:35 AM

MIAMI--(BUSINESS WIRE)--SafeStitch Medical®, Inc. (OTCBB:SFES), SafeStitch Medical today reported positive findings in a seven patient preliminary pilot clinical trial using its proprietary transluminal devices to restrict gastric acid reflux in three patients and to cause meaningful weight reduction in two obese patients after two years.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES